Real-World Effectiveness of Tralokinumab in Adults With Atopic Dermatitis: Interim Data on Improvements in Patients With Head and Neck Atopic Dermatitis After up to 9 Months of Treatment in the TRACE Study. J of Skin 2025, 9 (2), s574. https://doi.org/10.25251/skin.10.supp.574.